Biochemical and Biophysical Research Communications
Sperm-specific glyceraldehyde-3-phosphate dehydrogenase is expressed in melanoma cells
Highlights
► Melanoma cells were assayed for expression of sperm-specific glycolytic enzyme GAPDS. ► GAPDS fragment lacking N-terminal amino acid sequence is revealed in melanoma cells. ► The revealed GAPDS species form hybrid tetramers with somatic isoenzyme GAPD. ► Immunochemical staining of melanoma cells revealed native GAPDS in the cytoplasm.
Introduction
Genes expressed both in normal testes and in malignant tumors (Cancer/testes associated (СТА) genes) form a gene group that is being intensively investigated since it is important for the understanding of the mechanisms of the tumor genesis and for the search of new methods of diagnostics and treatment of the cancer. Nearly 100 CTA genes have been already identified, and their number is constantly growing. Nevertheless, a question that is constantly raised is whether the expression of testes-specific genes in cancer tumors is a random process accounted for the instability of the genome in cancer cells, or it is a specific feature of the growing tumor that is necessary for its development.
One of the specific features of cancer cells is the change in their metabolism. In normal cells, the functioning of the mitochondrial system of oxidative phosphorylation in the presence of oxygen results in the inhibition of glycolysis (Pasteur effect), but this effect is absent in cancer cells. Moreover, cancer cells are characterized by not only high intensity of glycolysis (anaerobic pathway of metabolism), but also by inhibition of respiration (Crabtree effect [1]). There is no unambiguous interpretation of these effects and their mechanisms, but it is assumed that the compartmentalization of glycolytic enzymes and interactions between them, as well as specific features of catalytic and regulatory mechanisms must be of importance for the regulation of the balance between glycolysis and oxidative phosphorylation.
It may be assumed that the expression of sperm-specific glycolytic enzymes in cancer cells could change the regulation of glycolysis and the coupled metabolic pathways. The expression of one of glycolytic enzymes, sperm-specific lactate dehydrogenase C was revealed in different human cancer tumors, and this enzyme was suggested to be responsible for the constitutive activation of the anaerobic pathway in cancer cells [2].
It should be noted that sperm-specific isoforms of glycolytic enzymes significantly differ from corresponding somatic isoenzymes in a number of catalytic and regulatory parameters, including stability and compartmentalization. The main function of these enzymes is to supply energy for the contractive elements of the principal part of the sperm flagellum providing progressive movement of the sperm (mitochondria were shown to provide only 20% of the energy [3]). Some glycolytic enzymes are firmly attached to the cytoskeleton of the flagellum (so called fibrous sheath [4]).
Sperm-specific glyceraldehyde-3-phosphate dehydrogenase (GAPDS) significantly differs from the somatic isoenzyme GAPD. GAPDS possesses an additional N-terminal sequence (72 amino acid residues in human) providing the attachment of the enzyme to the fibrous sheath of the sperm flagellum [5], [6] and exhibits an enhanced stability [7] compared to the somatic enzyme GAPD. Besides, the amino acid sequence of GAPDS lacks the motifs that are responsible for the translocation of the somatic enzyme GAPD through the nuclear membrane [8]. Thus, GAPDS cannot be involved in the apoptosis, the process controlled by the somatic GAPD [9], [10]. We assumed that GAPDS could be expressed in cancer cells, and the emergence of the protein with properties that differed from those of the somatic isoenzyme could significantly affect their metabolism and proliferation.
We analyzed information on the expression of GAPDS mRNA in 15322 samples that is available in the ArrayExpress Database (www.ebi.ac.uk/arrayexpress, accession numbers E-TABM-185, E-GEOD-2109, E-MTAB-37, E-MTAB-62, E-GEOD-7127, E-GEOD-10843 and E-GEOD-7307). By these data, the expression of GAPDS mRNA in most cancer cell lines, as well as in somatic tissues is virtually absent. At the same time, in some investigated melanoma cell lines, the content of GAPDS mRNA is close to its content in the testes. Consequently, the sperm-specific enzyme GAPDS could be found in melanoma cells.
In the present work, using different methods, we identified sperm-specific glyceraldehyde-3-phosphate dehydrogenase in several lines of human melanoma cells. Thus, subsequent investigation of this protein could be useful for the understanding of the role of GAPDS in the altered metabolism and proliferation of cancer cells.
Section snippets
Materials and methods
Melanoma cell lines MelIL, MelKor, and MelP were obtained previously during the collaborative work with Blokhin Cancer Research Center of Russian Academy of Medical Sciences and Petrov Research Institute of Oncology [11]. Primary cultures were isolated from metastatic tumors of patients suffering from melanoma. All cell lines were cultivated in a RPMI-1640 medium (HyClone, USA) with the addition of 10% fetal bovine serum (HyClone), 2 mM l-glutamine (HyClone), 100 U/ml penicillin (Sintez, Russia),
Results and discussion
Analysis of the expression of GAPDS mRNA in different cancer tissues showed an increased level of GAPDS mRNA in some melanoma cell lines (ArrayExpress database, www.ebi.ac.uk/arrayexpress, accession numbers E-MTAB-37, E-MTAB-62, E-GEOD-10843 and E-GEOD-7127). This suggested that the sperm-specific enzyme GAPDS could be revealed in melanoma cells.
On the first stage of our investigations, we assayed three different lines of melanoma cells for expression of GAPDS by Western blotting of the
Acknowledgments
This work was supported by the Russian Foundation of Basic Research (11-08-00663-а and 12-04-91330 NNiO_a), and DFG International Research Training Group “Regulation and Evolution of Cellular Systems” (GRK 1563).
References (18)
- et al.
Recombinant human sperm-specific glyceraldehyde-3-phosphate dehydrogenase structural basis for enhanced stability
Biochim. Biophys. Acta.
(2010) - et al.
Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids
Biochem. Biophys. Res. Commun.
(2003) - et al.
Purification of all glycolytic enzymes from one muscle extract
- et al.
Isolation of antibodies against different protein conformations using immunoaffinity chromatography
Anal. Biochem.
(2012) - et al.
Structure of insoluble rat sperm glyceraldehyde-3-phosphate dehydrogenase (GAPDH) via heterotetramer formation with Escherichia coli GAPDH reveals target for contraceptive design
J. Biol. Chem.
(2009) - et al.
A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress
J. Biol. Chem.
(2004) Observations on the carbohydrate metabolism of tumors
Biochem. J.
(1929)- et al.
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer
Cancer Res.
(2002) - et al.
Glycolysis plays a major role for adenosine triphosphate supplementation in mouse sperm flagellar movement
Biol. Reprod.
(2004)
Cited by (16)
Ethyl carbamate induces cell death through its effects on multiple metabolic pathways
2017, Chemico-Biological InteractionsCitation Excerpt :The downregulation of GAPDHS could explain the accumulation of NAD+ and/or NADP+ in EC treated cells (Supplementary Table 1-1), a sign of the failure for the continuation of glycolysis. Reduced expression of GAPDHS has also been reported in certain cancer cells [29]. Secondly, levels of glucose and other upstream glycolytic intermediates were remarkably reduced in 12 h EC treated cells, which was accompanied with the upregulation of cystathionine lyase (CTH).
Structural basis for regulation of stability and activity in glyceraldehyde-3-phosphate dehydrogenases. Differential scanning calorimetry and molecular dynamics
2015, Journal of Structural BiologyCitation Excerpt :GAPD is expressed in all tissues and dissolved in cytosol, whereas GAPDS is expressed only in sperms and bound to fibrous sheath (Feiden et al., 2008). However, the expression of GAPDS in somatic cells was detected in some cases (Kuravsky et al., 2011; Seidler, 2013) including melanoma cell lines (Sevostyanova et al., 2012). The functional and structural properties of GAPD from different sources have been extensively studied by a wide range of experimental techniques (Olsen, 1983; Levashov et al., 1999; Roitel et al., 2002, 2003; Jenkins and Tanner, 2006; Elkina et al., 2010; Chaikuad et al., 2011; Kuravsky et al., 2014).
Sperm-specific glyceraldehyde-3-phosphate dehydrogenase is stabilized by additional proline residues and an interdomain salt bridge
2014, Biochimica et Biophysica Acta - Proteins and ProteomicsCitation Excerpt :Stabilization of GAPDS presumably works towards the efficiency of the fertilization, increasing the life time of the enzyme that is necessary for the sperm motility. Interestingly that GAPDS without N-terminal domain was found in actively reproducing cells (embryonic and regenerating tissue cells) in the lizard Anolis carolinensis [6] and in some melanoma cell lines [24]. Given that the characteristic feature of proliferating systems, such as tumors and regenerative tissues, is a high rate of glycolysis and altered glucose metabolism [25], the expression of sperm-specific stable isoform of the glycolytic enzyme GAPDS in the intensively proliferating cells could give them some advantage in the energy production due to the increased lifetime of this isoenzyme compared to somatic GAPD.
The role of sperm-specific glyceraldehyde-3-phosphate dehydrogenase in the development of pathologies—from asthenozoospermia to carcinogenesis
2023, Frontiers in Molecular BiosciencesEnergy metabolism in mammalian sperm motility
2022, WIREs Mechanisms of Disease